0001209191-20-001250.txt : 20200103
0001209191-20-001250.hdr.sgml : 20200103
20200103172449
ACCESSION NUMBER: 0001209191-20-001250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wiley Matthew T.
CENTRAL INDEX KEY: 0001759703
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36621
FILM NUMBER: 20506878
MAIL ADDRESS:
STREET 1: C/O FOAMIX PHARMACEUTICALS LTD.
STREET 2: 2 HOLTZMAN ST, WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 7670402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd.
CENTRAL INDEX KEY: 0001606645
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
BUSINESS PHONE: 97289316233
MAIL ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
FORMER COMPANY:
FORMER CONFORMED NAME: Foamix Ltd.
DATE OF NAME CHANGE: 20140428
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-31
0
0001606645
Foamix Pharmaceuticals Ltd.
FOMX
0001759703
Wiley Matthew T.
C/O FOAMIX PHARMACEUTICALS LTD.
2 HOLZMAN STREET
REHOVOT
L3
7670402
ISRAEL
0
1
0
0
Chief Commercial Officer
Ordinary Shares
2019-12-31
4
F
0
2500
3.28
D
70782
D
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of the restricted share units and does not represent a sale by the Reporting Person.
/s/ Mutya Harsch as attorney-in-fact
2020-01-03